Endoscopy 2025; 57(S 02): S100-S101
DOI: 10.1055/s-0045-1805293
Abstracts | ESGE Days 2025
Oral presentation
Colorectal ESD: a revolution of innovation! 04/04/2025, 11:30 – 12:30 Room 120+121

The « DEBE » score predicts the risk of delayed bleeding after colorectal endoscopic dissection in a large European multicenter cohort

Authors

  • E Albéniz

    1   Navarrabiomed, Pamplona, Spain
    2   Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
    3   UPNA, Pamplona, Spain
    4   Navarra Hospital Complex – Navarra Hospital, Pamplona, Spain
  • M Pioche

    5   Edouard Herriot Hospital, Lyon, France
  • J C Marin-Gabriel

    6   University Hospital October 12, Madrid, Spain
    7   Universidad Complutense de Madrid, Madrid, Spain
    8   12 de Octubre (i+12) Research Institute, Madrid, Spain
  • A Herreros-De-Tejada

    9   Puerta de Hierro Majadahonda University Hospital, Majadahonda, Spain
    10   IDIPHISA, Majadahonda, Spain
  • T Wallenhorst

    11   Pontchaillou University Hospital Center, Rennes, France
  • R Jerome

    12   Hospital Edouard Herriot – Hcl, Lyon, France
  • L Romain

    13   CHU Dupuytren 1, Limoges, France
  • T Degand

    14   Chu Dijon, Dijon, France
  • M Schaefer

    15   CHRU de Nancy – Hôpitaux de Brabois, Nancy, France
  • J B Chevaux

    15   CHRU de Nancy – Hôpitaux de Brabois, Nancy, France
  • F Ramos Zabala

    16   University Hospital HM Montepríncipe, Monteprincipe, Spain
  • Y Le Baleur

    17   Hospital Paris Saint-Joseph, Paris, France
  • F Rostain

    5   Edouard Herriot Hospital, Lyon, France
  • A Berger

    18   CHU Bordeaux, Pessac, France
  • P Rosón Rodriguez

    19   Hospital Quirónsalud Málaga, Málaga, Spain
    20   Xanit Hospital, Benalmádena, Spain
  • Á Terán

    21   Marqués de Valdecilla University Hospital, Santander, Spain
  • A Lupu

    5   Edouard Herriot Hospital, Lyon, France
  • J Santiago Garcia

    10   IDIPHISA, Majadahonda, Spain
    9   Puerta de Hierro Majadahonda University Hospital, Majadahonda, Spain
  • E Chabrun

    22   Clinique de l'Anjou, Angers, France
  • H Lepetit

    13   CHU Dupuytren 1, Limoges, France
  • B Brieau

    23   Jules Verne Clinic, Nantes, France
  • B Maximilien

    24   Cochin Hospital, Paris, France
  • H Uchima

    25   Teknon Medical Center, Barcelona, Spain
    26   Hospital Germans Trias i Pujol, Badalona, Spain
  • F Gallego Rojo

    27   Hospital Universitario Poniente, El Ejido, Spain
  • J De La Peña

    21   Marqués de Valdecilla University Hospital, Santander, Spain
  • A Jeremie

    13   CHU Dupuytren 1, Limoges, France
  • P Bonniaud

    5   Edouard Herriot Hospital, Lyon, France
  • S Chaussade

    24   Cochin Hospital, Paris, France
  • J Rodríguez Sánchez

    6   University Hospital October 12, Madrid, Spain
    28   HGU Ciudad Real, Ciudad Real, Spain
  • A Amoros Tenorio

    29   Our Lady of Candelaria University Hospital, Santa Cruz de Tenerife, Spain
  • A Belle

    24   Cochin Hospital, Paris, France
  • M Dahan

    13   CHU Dupuytren 1, Limoges, France
  • D García Romero

    29   Our Lady of Candelaria University Hospital, Santa Cruz de Tenerife, Spain
  • P Leclercq

    30   Clinical Chc Montlégia, Luik, Belgium
    31   University Hospitals Leuven, Leuven, Belgium
  • E Rodriguez de Santiago

    32   Ramón y Cajal Hospital, Madrid, Spain
  • S Parejo

    32   Ramón y Cajal Hospital, Madrid, Spain
  • O Nogales

    33   Gregorio Marañón General University Hospital, Madrid, Spain
  • O Plomteux

    30   Clinical Chc Montlégia, Luik, Belgium
  • J B Zeevaert

    34   CHR Verviers, Verviers, Belgium
  • G Fernández-Esparrach

    35   Hospital Clínic de Barcelona, Barcelona, Spain
  • A Sanchez-Yague

    36   Hospital Costa del Sol, Marbella, Spain
  • U Goikoetxea

    37   Donostia University Hospital, Donostia, Spain
  • T Grainville

    11   Pontchaillou University Hospital Center, Rennes, France
  • F Estremera-Arevalo

    4   Navarra Hospital Complex – Navarra Hospital, Pamplona, Spain
  • M Gómez Alonso

    4   Navarra Hospital Complex – Navarra Hospital, Pamplona, Spain
  • M Enguita

    1   Navarrabiomed, Pamplona, Spain
  • S Montori

    1   Navarrabiomed, Pamplona, Spain
  • J Jacques

    13   CHU Dupuytren 1, Limoges, France
 

Aims Clinically significant delayed bleeding (DB) is an important adverse event after endoscopic submucosal dissection (ESD) of large non-pedunculated colorectal polyps. The Limoges scores1 estimated an individualized DB risk after ESD. The aim of this study is to evaluate the incidence and risk factors of DB after ESD in a large European cohort, to validate the Limoges score and to create a new updated one.

Methods Procedural data and complications occurring within 30 days after ESD were prospectively recorded in French, Belgian, and Spanish centers and analyzed retrospectively. The Limoges score was tested in the European cohort. Multivariate logistic regression analysis on risk factors allowed the development of a prediction model using weighted points in a risk score. Model accuracy was determined by discrimination and calibration. Internal validation was performed by bootstrapping and leave-one-out cross-validation. The score was studied in two geographical areas (Spain, France/Belgium).

Results 4771 ESD procedures were included : 23.7% rectal ESD ; median lesion size 50 mm ; mean age 68.2 years-old ; 72.9% ASA score I-II. Anticoagulants use in 10.9% and antiplatelet in 17%. DB was observed in 6.8% of cases. The discrimination of “Limoges score” was modest (AUC 0.682) A new European model called DEBE (DElayed Bleeding Esd) score was developed with the main risk factors: age≥75 years (2 points), lesion size≥50 mm (5 points), ASA classification III-IV (4 points), location in the rectum (2 points) or in the proximal colon (1 point), anticoagulants (7 points) or antiplatelets (3 points). The DEBE score ranges from 0 (lowest risk) to 23 points (highest) and divided patients into a low-risk group (DB risk 3.9%) and an intermediate-high-risk group (14.2%). The DEBE score shows better discrimination (AUC 0.712 (95% CI 0.682 – 0.743). Calibration and Hosmer-Lemeshow test (chi-square 4.322, p=0.827) were satisfactory in the derivation cohort. Cross-validation also showed an adequate model performance of 72.6% and demonstrated adequate performance in both datasets [1].

Conclusions -A new developed European model called the DEBE score has an improved and validated performance to identify the individual risk of bleeding after colorectal ESD.

-The model is based on 5 pre-procedural variables and allows a personalized assessment of the bleeding risk. It permits the clinician to inform the patient about the DB risk, to select the patients most likely to benefit from prophylactic treatments and to define those requiring strict monitoring after the procedure.



Publication History

Article published online:
27 March 2025

© 2025. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany